Mitchell Keegan
CIK 1471556 · View on SEC EDGAR ↗
First SEC filing: Sept. 9, 2009 · Latest: Sept. 9, 2009
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 7, 2011 | CRIS | A | 29,746 | — | — | 29,746 Direct | — | Acquired | (price as of 2026-08-19) |
| Jan. 7, 2011 | CRIS | A | 30,254 | — | — | 30,254 Direct | — | Acquired | (price as of 2026-08-19) |
| Feb. 2, 2010 | CRIS | A | 34,717 | — | — | 34,717 Direct | — | Acquired | (price as of 2026-08-19) |
| Feb. 2, 2010 | CRIS | A | 25,283 | — | — | 25,283 Direct | — | Acquired | (price as of 2026-08-19) |
| Sept. 2, 2009 | CRIS | A | 18,861 | — | — | 18,861 Direct | — | Acquired | (price as of 2026-08-19) |
| Sept. 2, 2009 | CRIS | A | 81,139 | — | — | 81,139 Direct | — | Acquired | (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 7, 2011 | CRIS | Non-qualified stock option (right to buy) | Common stock (29,746) | $2.15 | Jan. 7, 2021 | 29,746 | Acquired |
| Jan. 7, 2011 | CRIS | Qualified stock option (right to buy) | Common stock (30,254) | $2.15 | Jan. 7, 2021 | 30,254 | Acquired |
| Feb. 2, 2010 | CRIS | Non-qualified stock option (right to buy) | Common stock (34,717) | $2.27 | Feb. 2, 2020 | 34,717 | Acquired |
| Feb. 2, 2010 | CRIS | Qualified stock option (right to buy) | Common stock (25,283) | $2.27 | Feb. 2, 2020 | 25,283 | Acquired |
| Sept. 2, 2009 | CRIS | Non-qualified stock option (right to buy) | Common stock (18,861) | $2.10 | Sept. 2, 2019 | 18,861 | Acquired |
| Sept. 2, 2009 | CRIS | Qualified stock option (right to buy) | Common stock (81,139) | $2.10 | Sept. 2, 2019 | 81,139 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 6 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Sept. 9, 2009 | CRIS | Qualified stock option (right to buy)→ Common Stock (150,000) | 150,000 | Direct |
| Sept. 9, 2009 | CRIS | Qualified stock option (right to buy)→ Common Stock (18,750) | 18,750 | Direct |
| Sept. 9, 2009 | CRIS | Qualified stock option (right to buy)→ Common Stock (27,500) | 27,500 | Direct |
| Sept. 4, 2009 | CRIS | Qualified stock option (right to buy)→ Common Stock (150,000) | 150,000 | Direct |
| Sept. 4, 2009 | CRIS | Qualified stock option (right to buy)→ Common Stock (18,750) | 18,750 | Direct |
| Sept. 4, 2009 | CRIS | Qualified stock option (right to buy)→ Common Stock (27,500) | 27,500 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CRIS
President, Development| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2011 | — | — | — | — | — | — | — | — |
| 2010 | $247,981,233,654 | — | — | — | — | — | $735,012,808 | $408,512,397,936 |
| 2009 | $233,654 | — | — | — | — | — | $12,808 | $397,936 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.